Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Vijaypd CeuticalNSE:VIJAYPD -1.09%12 Altman Z-Score is 3.20 as of Jul. 29, 2026, which is 1% below its 10-year median of 3.24. GuruFocus rates NSE:VIJAYPD with a GF Score™ of 12/100. The stock has 7 warning signs investors should review. Among 657 Healthcare Providers & Services companies, Vijaypd Ceutical ranks better than 62.1% on this metric.
The Altman Z-Score is a model designed to predict the likelihood of a company going bankrupt within the next two years. Created by American finance professor Edward Altman in 1968, the model is specifically designed for publicly traded manufacturing companies with assets greater than $1 million.
Good Sign:
Altman Z-score of 3.21 is strong.
Vijaypd Ceutical has a Altman Z-Score of 3.20, indicating it is in Safe Zones. This implies the Altman Z-Score is strong.
The zones of discrimination were as such:
When Altman Z-Score <= 1.8, it is in Distress Zones.
When Altman Z-Score >= 3, it is in Safe Zones.
When Altman Z-Score is between 1.8 and 3, it is in Grey Zones.
The historical rank and industry rank for Vijaypd Ceutical's Altman Z-Score or its related term are showing as below:
NSE:VIJAYPD'
s Altman Z-Score Range Over the Past 10 Years
Min: 3.21 Med: 3.24 Max: 3.24
Current: 3.21
During the past 4 years, Vijaypd Ceutical's highest Altman Z-Score was 3.24. The lowest was 3.21. And the median was 3.24.
X1: The Working Capital/Total Assets (WC/TA) ratio is a measure of the net liquid assets of the firm relative to the total capitalization. Working capital is defined as the difference between current assets and current liabilities. Ordinarily, a firm experiencing consistent operating losses will have shrinking current assets in relation to total assets. Altman found this one proved to be the most valuable liquidity ratio comparing with the current ratio and the quick ratio. This is however the least significant of the five factors.
X2: Retained Earnings/Total Assets: the RE/TA ratio measures the leverage of a firm. Retained earnings is the account which reports the total amount of reinvested earnings and/or losses of a firm over its entire life. Those firms with high RE, relative to TA, have financed their assets through retention of profits and have not utilized as much debt.
X3, Earnings Before Interest and Taxes/Total Assets (EBIT/TA): This ratio is a measure of the true productivity of the firm's assets, independent of any tax or leverage factors. Since a firm's ultimate existence is based on the earning power of its assets, this ratio appears to be particularly appropriate for studies dealing with corporate failure. This ratio continually outperforms other profitability measures, including cash flow.
X4, Market Value of Equity/Book Value of Total Liabilities (MVE/TL): The measure shows how much the firm's assets can decline in value (measured by market value of equity plus debt) before the liabilities exceed the assets and the firm becomes insolvent.
X5, Revenue/Total Assets (S/TA): The capital-turnover ratio is a standard financial ratio illustrating the sales generating ability of the firm's assets.
Altman Z-Score does not apply to financial companies.
Vijaypd Ceutical Altman Z-Score Related Terms
Vijaypd Ceutical Altman Z-Score Historical Data
* Premium members only.
The historical data trend for Vijaypd Ceutical's Altman Z-Score can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Pharmaceutical Retailers subindustry, Vijaypd Ceutical's Altman Z-Score, along with its competitors' market caps and Altman Z-Score data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vijaypd Ceutical Altman Z-Score vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Vijaypd Ceutical's Altman Z-Score distribution charts can be found below:
* The bar in red indicates where Vijaypd Ceutical's Altman Z-Score falls into.
Altman Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.
Vijaypd Ceutical's Altman Z-Score for today is calculated with this formula:
Z
=
1.2
*
X1
+
1.4
*
X2
+
3.3
*
X3
+
0.6
*
X4
+
1.0
*
X5
=
1.2
*
0.3302
+
1.4
*
0
+
3.3
*
0.0807
+
0.6
*
2.5678
+
1.0
*
0.9954
=
3.20
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency. GuruFocus does not calculate Altman Z-Score when X4 or X5 value is 0.
Vijaypd Ceutical (NSE:VIJAYPD) has a Altman Z-Score of 3.20 as of Jul. 29, 2026. The Altman Z-score measures a company's bankruptcy risk. View historical data on Vijaypd Ceutical and its competitors. This is near median its historical median of 3.24. Over the past decade, Vijaypd Ceutical's Altman Z-Score has ranged from 3.21 to 3.24. According to the industry distribution chart, Vijaypd Ceutical ranks #249 out of 657 companies in the Healthcare Providers & Services industry, placing it in the top 37.9%.
Is Vijaypd Ceutical's Altman Z-Score too high?
Vijaypd Ceutical's current Altman Z-Score of 3.20 is near median its 10-year median of 3.24. Over the past 10 years, this metric has ranged from a low of 3.21 to a high of 3.24. The Healthcare Providers & Services industry median Altman Z-Score is 2.44. Vijaypd Ceutical's value of 3.20 is 31.1% above this industry median. Based on the distribution chart, Vijaypd Ceutical ranks #249 out of 657 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Vijaypd Ceutical has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Vijaypd Ceutical's Altman Z-Score compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Vijaypd Ceutical ranks #249 out of 657 companies for Altman Z-Score. This puts Vijaypd Ceutical in the upper half of its industry. The industry median Altman Z-Score is 2.44. Vijaypd Ceutical's value of 3.20 is 31.1% above this benchmark. Historically, Vijaypd Ceutical's own Altman Z-Score has ranged from 3.21 to 3.24 over the past decade. While the company's 10-year median is 3.24 vs. the industry median of 2.44, Vijaypd Ceutical has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Altman Z-Score for a Healthcare Providers & Services company?
The median Altman Z-Score among Healthcare Providers & Services companies is 2.44, based on 657 companies in the industry. Companies in the top quartile (top 25%) have a Altman Z-Score significantly above this median, while those in the bottom quartile fall well below. However, Altman Z-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Vijaypd Ceutical's current Altman Z-Score of 3.20 is 31.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Altman Z-Score mean?
A high Altman Z-Score can signal that a stock is expensive relative to its fundamentals. The Altman Z-score measures a company's bankruptcy risk. View historical data on Vijaypd Ceutical and its competitors. For the Healthcare Providers & Services industry, the median Altman Z-Score is 2.44 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vijaypd Ceutical's current Altman Z-Score is 3.20, which is near median its own 10-year median of 3.24. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vijaypd Ceutical stock overvalued right now?
Vijaypd Ceutical (NSE:VIJAYPD) has a current Altman Z-Score of 3.20. The current Altman Z-Score is 3.20, which is near median its 10-year median of 3.24 and 31.1% above the Healthcare Providers & Services industry median of 2.44. Vijaypd Ceutical's overall GF Score™ is 12/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Altman Z-Score calculated?
Altman Z-Score is calculated from a company's financial statements. For Vijaypd Ceutical (NSE:VIJAYPD), the current Altman Z-Score is 3.20 as of Jul. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Vijaypd Ceutical Ltd is engaged in the business of distribution and supply within the pharmaceutical and consumer goods sectors, offering a comprehensive range of services. Its roles include being representatives, dealers, agents, stockists, suppliers, traders, and packers. The company offers a wide range of products serving both the pharmaceutical and wellness industries, as well as the fastmoving consumer goods (FMCG) market. Its pharmaceutical and wellness product range includes medicines such as injections, tablets, capsules, ointments, suppositories, ophthalmic preparations, and liquid oral formulations. It also supply vitamins, hormones, enzymes, wellness tonics, serums, and diagnostic test kits.
12GF Score
Get the complete analysis for NSE:VIJAYPD
Altman Z-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:VIJAYPD has been successfully added to your 
